Institutional Review Board Statement
WEST
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the French Agency for the Safety of Health Products “ANSM” (number: 2016-A01144-47) as well as by the Ethics Committee “CPP West III” on 26 June 2015.